Prospective direct comparison of biologic treatments for severe eosinophilic asthma (2023)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.anai.2023.11.005
Publication URI: http://dx.doi.org/10.1016/j.anai.2023.11.005
Type: Journal Article/Review
Parent Publication: Annals of Allergy, Asthma & Immunology